Lumida
/AQST
⌘K
Aquestive Therapeutics Inc

Aquestive Therapeutics Inc

AQST
$4.78USD↓-4.21%-0.21 today

MARKET CAP

599.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$3
$8

AI Summary

Stalk
Buy NowMedium

Stage 2 advancing remains intact despite the late‐June exhaustion signal. Price has retraced into the rising 9/21/50 EMA confluence on neutral RSI and OB/OS context, offering a disciplined entry. Speculative intent favors buying this pullback while preserving the uptrend and monitoring for an EMA breach.

  • ↑Positive Anaphylm PK/usability studies bolster FDA approval prospects.
  • ↑Q2 revenue $13.82M (+18% YoY) with FY guidance of $46–50M.
  • ↓Net loss $22.9M in Q2 highlights persistent cash burn.
Full analysis →

Buying

5

institutions

Selling

7

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY8.07 M33.57 M+560.30 K+7.7%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL744.54 K3.10 M+-2.16 M-74.3%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL710.90 K2.96 M+-308.61 K-30.1%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW416.25 K1.73 M+416.25 K+0.0%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW351.70 K1.46 M+351.70 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY201.94 K840.08 K+150.35 K+292.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY124.50 K517.94 K+60.07 K+99.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL16.60 K69.07 K+-2.20 K-11.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-283.73 K-100.0%0.00%
JH

Janus Henderson Group Plc

Q1 2026

SELL0.000.00+-226.70 K-100.0%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-25.85 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-10.00 K-100.0%0.00%